Prognostic value of haemoglobin A1c and fasting plasma glucose for incident diabetes and implications for screening

Accuracy and Precision of Glucose Monitoring Are Relevant to Treatment Decision-Making and Clinical Outcome in Hospitalized Patients with Diabetes

(2011) Christina Voulgari et al.   Diabetes Technology & Therapeutics

Alcohol Consumption, Serum Gamma-Glutamyltransferase, and Helicobacter Pylori Infection in a Population-Based Study Among 9733 Older Adults

(2010) Lei Gao et al.   ANNALS OF EPIDEMIOLOGY

Common Variants at 10 Genomic Loci Influence Hemoglobin A1C Levels via Glycemic and Nonglycemic Pathways

(2010) N. Soranzo et al.   DIABETES

The Association of Hemoglobin A1c With Incident Heart Failure Among People Without Diabetes: The Atherosclerosis Risk in Communities Study

(2010) Kunihiro Matsushita et al.   DIABETES

A1C Between 5.7 and 6.4% as a Marker for Identifying Pre-Diabetes, Insulin Sensitivity and Secretion, and Cardiovascular Risk Factors: The Insulin Resistance Atherosclerosis Study (IRAS)

(2010) C. Lorenzo et al.   DIABETES CARE

The potential for a two-stage diabetes risk algorithm combining non-laboratory-based scores with subsequent routine non-fasting blood tests: results from prospective studies in older men and women

(2010) S. G. Wannamethee et al.   DIABETIC MEDICINE

Iron-deficiency anemia, non-iron-deficiency anemia and HbA1c among adults in the US*

(2010) Earl S. FORD et al.   Journal of Diabetes

Combined Measurement of Fasting Plasma Glucose and A1C Is Effective for the Prediction of Type 2 Diabetes: The Kansai Healthcare Study

(2009) K. K. Sato et al.   DIABETES CARE

International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes

(2009)   DIABETES CARE

Hemoglobin A1c in predicting progression to diabetes

(2009) Tomoko Nakagami et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Unfavourable risk factors for type 2 diabetes mellitus are already apparent more than a decade before onset in a population-based study of older persons: from the Age, Gene/Environment Susceptibility—Reykjavik Study (AGES-Reykjavik)

(2009) Elin Olafsdottir et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Validation of an algorithm combining haemoglobin A1cand fasting plasma glucose for diagnosis of diabetes mellitus in UK and Australian populations

(2008) S. E. Manley et al.   DIABETIC MEDICINE

For the majority of patients with diabetes blood pressure and lipid management is not in line with recommendations. Results from a large population-based cohort in Germany

(2008) Elke Raum et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY